The long expected pipeline and team is finally here. Necessary financing expected to move the pipeline closer to approval. With trials on its way, moving the assets provide potential for partnerships or sale.
Acquisition of MS Precise brings potential to generate revenue. This Genius play from Gerald and team comes with a $7.5mm New Jersey Tax credit that nearly pays for itself. This potential revenue generator is 12-24 months from providing cashflow. Multiple Sclerosis diagnostics across the industry has the potential to generate $400mm in the US alone and will be a huge saving to our tax payers by increasing the accuracy and limiting misdiagnosis.
News 
Market Data 
Discover 
